Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit J Arsenault

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Current Cardiology Reports|June 19, 2012
Regression of atherosclerosisBenoit J Arsenault, Ekaterini A Kritikou, Jean-Claude Tardif
European Heart Journal Open|March 31, 2025
Remnant cholesterol concentrations best explain the cardiovascular benefit of APOC3 genetic inhibition: a drug target Mendelian randomization studyEloi Gagnon, Dipender Gill, Stephen Burgess, et al.
Current Opinion in Lipidology|January 19, 2016
What does the future hold for cholesteryl ester transfer protein inhibition?Benoit J Arsenault, Marjorie Boyer, John J P Kastelein
Atherosclerosis|November 29, 2023
Disentangling the impact of gluteofemoral versus visceral fat accumulation on cardiometabolic health using sex-stratified Mendelian randomizationEloi Gagnon, Audrey Paulin, Patricia L Mitchell, et al.
Annals of Medicine|July 9, 2008
The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiologyJean-pierre Després, Amélie Cartier, Mélanie Côté, et al.
Nature Reviews. Cardiology|February 2, 2011
Lipid parameters for measuring risk of cardiovascular diseaseBenoit J Arsenault, S Matthijs Boekholdt, John J P Kastelein
American Journal of Preventive Cardiology|July 6, 2026
Sex-specific associations of social determinants of health and genetic risk factors with atherosclerotic cardiovascular diseases incidence in the general populationAudrey Paulin, Louis-Jacques Ruel, Sébastien Thériault, et al.
Annals of Medicine|December 14, 2011
Mapping body fat distribution: a key step towards the identification of the vulnerable patient?Benoit J Arsenault, Emilie Pelletier Beaumont, Jean-Pierre Després, et al.
Future Cardiology|August 9, 2012
An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levelsDavid Rhainds, Benoit J Arsenault, Mathieu R Brodeur, et al.
Atherosclerosis|May 4, 2024
Impact of loss-of-function in angiopoietin-like 4 on the human phenomeEloi Gagnon, Jérome Bourgault, Émilie Gobeil, et al.
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Current Cardiology Reports|June 19, 2012
Regression of atherosclerosisBenoit J Arsenault, Ekaterini A Kritikou, Jean-Claude Tardif
European Heart Journal Open|March 31, 2025
Remnant cholesterol concentrations best explain the cardiovascular benefit of APOC3 genetic inhibition: a drug target Mendelian randomization studyEloi Gagnon, Dipender Gill, Stephen Burgess, et al.
Current Opinion in Lipidology|January 19, 2016
What does the future hold for cholesteryl ester transfer protein inhibition?Benoit J Arsenault, Marjorie Boyer, John J P Kastelein
Atherosclerosis|November 29, 2023
Disentangling the impact of gluteofemoral versus visceral fat accumulation on cardiometabolic health using sex-stratified Mendelian randomizationEloi Gagnon, Audrey Paulin, Patricia L Mitchell, et al.
Annals of Medicine|July 9, 2008
The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiologyJean-pierre Després, Amélie Cartier, Mélanie Côté, et al.
Nature Reviews. Cardiology|February 2, 2011
Lipid parameters for measuring risk of cardiovascular diseaseBenoit J Arsenault, S Matthijs Boekholdt, John J P Kastelein
American Journal of Preventive Cardiology|July 6, 2026
Sex-specific associations of social determinants of health and genetic risk factors with atherosclerotic cardiovascular diseases incidence in the general populationAudrey Paulin, Louis-Jacques Ruel, Sébastien Thériault, et al.
Annals of Medicine|December 14, 2011
Mapping body fat distribution: a key step towards the identification of the vulnerable patient?Benoit J Arsenault, Emilie Pelletier Beaumont, Jean-Pierre Després, et al.
Future Cardiology|August 9, 2012
An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levelsDavid Rhainds, Benoit J Arsenault, Mathieu R Brodeur, et al.
Atherosclerosis|May 4, 2024
Impact of loss-of-function in angiopoietin-like 4 on the human phenomeEloi Gagnon, Jérome Bourgault, Émilie Gobeil, et al.
Pageof 16